BridgeMD
New treatment option for Chronic Insomnia
Official title Facial Emotion Recognition in Insomnia and Emotional Regulation
ClinicalTrials.gov ID: NCT06251258
What this study is testing
- What it's testing
- Introduction Chronic insomnia is a prevalent disorder in the general population, affecting up to 20% according to French National Institute of Health and Medical Research, leading to a decline in quality of life and an increased risk of developing certain psychiatric disorders, notably major depressive episodes. Chronic insomnia, particularly when accompanied by reduced sleep duration, has been associated with cognitive impairments documented in the literature, such as reduced concentration, working memory, vigilance, and certain executive functions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Pre- Age between 18 and 65
- Signed consent to participate in the study
- Person affiliated to or benefiting from a social security scheme
- For insomnia group: known insomnia (patient treated for insomnia)
- Insomnia group: ISI \>14 (between 15 and 28 = clinical insomnia)
See the full eligibility criteria
- Pre- Age between 18 and 65
- Signed consent to participate in the study
- Person affiliated to or benefiting from a social security scheme
- For insomnia group: known insomnia (patient treated for insomnia)
- Insomnia group: ISI \>14 (between 15 and 28 = clinical insomnia)
- Control group: ISI \< 8 (between 0 and 7 = no insomnia) Non-pre- Known psychiatric disorders (Characterized depressive episode, Bipolar disorder, Schizophrenia and other delusional disorders, Specified anxiety disorder...
- Taking antidepressant, neuroleptic or thymoregulator medication
- Taking a benzodiazepine with a long half-life (\>12 hours)
- Condition requiring hospitalization in the month preceding the study
- Known sequelae or progressive neurological disease
- Known significant ophthalmological condition
- Pregnancy or breast-feeding
- Person deprived of liberty by judicial or administrative decision
- Person subject to a legal protection measure
- Person under psychiatric care without consent
- For control group: no known insomnia Non- \- Psychiatric disorders identified during psychiatric interview
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.